Cite
Lissoni P, Ardizzoia A, Barni S, et al. A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients. Oncol Rep. 1995;2(5):871-3doi: 10.3892/or.2.5.871.
Lissoni, P., Ardizzoia, A., Barni, S., Paolorossi, F., Tancini, G., Meregalli, S., Esposti, D., Zubelewicz, B., & Braczowski, R. (1995). A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients. Oncology reports, 2(5), 871-3. https://doi.org/10.3892/or.2.5.871
Lissoni, P, et al. "A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients." Oncology reports vol. 2,5 (1995): 871-3. doi: https://doi.org/10.3892/or.2.5.871
Lissoni P, Ardizzoia A, Barni S, Paolorossi F, Tancini G, Meregalli S, Esposti D, Zubelewicz B, Braczowski R. A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients. Oncol Rep. 1995 Sep;2(5):871-3. doi: 10.3892/or.2.5.871. PMID: 21597833.
Copy
Download .nbib